These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35687133)

  • 1. TBX2 acts as a potent transcriptional silencer of tumour suppressor genes through interaction with the CoREST complex to sustain the proliferation of breast cancers.
    McIntyre AJ; Angel CZ; Smith JS; Templeman A; Beattie K; Beattie S; Ormrod A; Devlin E; McGreevy C; Bothwell C; Eddie SL; Buckley NE; Williams R; Mullan PB
    Nucleic Acids Res; 2022 Jun; 50(11):6154-6173. PubMed ID: 35687133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells.
    Crawford NT; McIntyre AJ; McCormick A; D'Costa ZC; Buckley NE; Mullan PB
    Oncogene; 2019 Aug; 38(31):5971-5986. PubMed ID: 31253870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.
    Redmond KL; Crawford NT; Farmer H; D'Costa ZC; O'Brien GJ; Buckley NE; Kennedy RD; Johnston PG; Harkin DP; Mullan PB
    Oncogene; 2010 Jun; 29(22):3252-62. PubMed ID: 20348948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
    D'Costa ZC; Higgins C; Ong CW; Irwin GW; Boyle D; McArt DG; McCloskey K; Buckley NE; Crawford NT; Thiagarajan L; Murray JT; Kennedy RD; Mulligan KA; Harkin DP; Waugh DJ; Scott CJ; Salto-Tellez M; Williams R; Mullan PB
    Oncotarget; 2014 Mar; 5(6):1609-20. PubMed ID: 24742492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T box transcription factor TBX2 promotes epithelial-mesenchymal transition and invasion of normal and malignant breast epithelial cells.
    Wang B; Lindley LE; Fernandez-Vega V; Rieger ME; Sims AH; Briegel KJ
    PLoS One; 2012; 7(7):e41355. PubMed ID: 22844464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence.
    Martin N; Benhamed M; Nacerddine K; Demarque MD; van Lohuizen M; Dejean A; Bischof O
    EMBO J; 2012 Jan; 31(1):95-109. PubMed ID: 22002537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene.
    Ambrosio S; Amente S; Saccà CD; Capasso M; Calogero RA; Lania L; Majello B
    Oncotarget; 2017 Jan; 8(3):3854-3869. PubMed ID: 27894074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
    Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
    Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UV-mediated regulation of the anti-senescence factor Tbx2.
    Abrahams A; Mowla S; Parker MI; Goding CR; Prince S
    J Biol Chem; 2008 Jan; 283(4):2223-30. PubMed ID: 18025091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZNF516 suppresses EGFR by targeting the CtBP/LSD1/CoREST complex to chromatin.
    Li L; Liu X; He L; Yang J; Pei F; Li W; Liu S; Chen Z; Xie G; Xu B; Ting X; Zhang Z; Jin T; Liu X; Zhang W; Yuan S; Yang Z; Wu C; Zhang Y; Yang X; Yi X; Liang J; Shang Y; Sun L
    Nat Commun; 2017 Sep; 8(1):691. PubMed ID: 28947780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microphthalmia-associated transcription factor/T-box factor-2 axis acts through Cyclin D1 to regulate melanocyte proliferation.
    Pan L; Ma X; Wen B; Su Z; Zheng X; Liu Y; Li H; Chen Y; Wang J; Lu F; Qu J; Hou L
    Cell Prolif; 2015 Dec; 48(6):631-42. PubMed ID: 26486273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined genomic and proteomic approaches reveal DNA binding sites and interaction partners of TBX2 in the developing lung.
    Lüdtke TH; Wojahn I; Kleppa MJ; Schierstaedt J; Christoffels VM; Künzler P; Kispert A
    Respir Res; 2021 Mar; 22(1):85. PubMed ID: 33731112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis.
    Cai CL; Zhou W; Yang L; Bu L; Qyang Y; Zhang X; Li X; Rosenfeld MG; Chen J; Evans S
    Development; 2005 May; 132(10):2475-87. PubMed ID: 15843407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine resistance and breast cancer plasticity are controlled by CoREST.
    Garcia-Martinez L; Adams AM; Chan HL; Nakata Y; Weich N; Stransky S; Zhang Z; Alshalalfa M; Sarria L; Mahal BA; Kesmodel SB; Celià-Terrassa T; Liu Z; Minucci S; Bilbao D; Sidoli S; Verdun RE; Morey L
    Nat Struct Mol Biol; 2022 Nov; 29(11):1122-1135. PubMed ID: 36344844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complex.
    Thillainadesan G; Isovic M; Loney E; Andrews J; Tini M; Torchia J
    Mol Cell Biol; 2008 Oct; 28(19):6066-77. PubMed ID: 18625718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tbx2 is overexpressed and plays an important role in maintaining proliferation and suppression of senescence in melanomas.
    Vance KW; Carreira S; Brosch G; Goding CR
    Cancer Res; 2005 Mar; 65(6):2260-8. PubMed ID: 15781639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells.
    Zhu B; Zhang M; Byrum SD; Tackett AJ; Davie JK
    Int J Cancer; 2014 Aug; 135(4):785-97. PubMed ID: 24470334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.
    Nandana S; Tripathi M; Duan P; Chu CY; Mishra R; Liu C; Jin R; Yamashita H; Zayzafoon M; Bhowmick NA; Zhau HE; Matusik RJ; Chung LW
    Cancer Res; 2017 Mar; 77(6):1331-1344. PubMed ID: 28108510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anti-proliferative function of the TGF-β1 signaling pathway involves the repression of the oncogenic TBX2 by its homologue TBX3.
    Li J; Ballim D; Rodriguez M; Cui R; Goding CR; Teng H; Prince S
    J Biol Chem; 2014 Dec; 289(51):35633-43. PubMed ID: 25371204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel role for the anti-senescence factor TBX2 in DNA repair and cisplatin resistance.
    Wansleben S; Davis E; Peres J; Prince S
    Cell Death Dis; 2013 Oct; 4(10):e846. PubMed ID: 24113180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.